IGC Pharma (IGC) Return on Sales [ROS] (2010 - 2026)
IGC Pharma's Return on Sales [ROS] was -775.39% in FY2026, down 189.56 percentage points from -585.84% in FY2025.
Powered by 
Analysis
IGC Pharma (IGC) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
From FY2011 onward, IGC Pharma has reported Return on Sales [ROS] for 16 years.
- Return on Sales [ROS] shows a five-year change of +196.10 percentage points (FY2021 to FY2026).
- The FY2026 figure marks the lowest annual Return on Sales [ROS] since FY2023.
- Per Business Quant data, Return on Sales [ROS] in earlier years was -585.84% in FY2025 (+142.64 pp), -728.48% in FY2024 (+541.67 pp), -1270.14% in FY2023 (+2616.00 pp) and -3886.15% in FY2022 (-2914.65 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | IGC Pharma | 24.52 Mn | 21.76 Mn | 55,000.00 | -775.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -775.39% |
| Sep 30, 2025 | -1,517.80% |
| Jun 30, 2025 | -580.79% |
| Mar 31, 2025 | -428.18% |
| Dec 31, 2024 | -730.74% |
| Sep 30, 2024 | -427.18% |
| Jun 30, 2024 | -880.88% |
| Mar 31, 2024 | -735.59% |
| Dec 31, 2023 | -1,469.61% |
| Sep 30, 2023 | -856.01% |
| Jun 30, 2023 | -385.41% |
| Mar 31, 2023 | -2,433.13% |
| Dec 31, 2022 | -686.14% |
| Sep 30, 2022 | -1,231.68% |
| Jun 30, 2022 | -1,321.70% |
| Mar 31, 2022 | -5,328.69% |
| Dec 31, 2021 | -1,679.58% |
| Sep 30, 2021 | -7,764.29% |
| Jun 30, 2021 | -2,849.35% |
| Mar 31, 2021 | -3,445.68% |
API Access
IGC Pharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();